Logo image of EHC

ENCOMPASS HEALTH CORP (EHC) Stock Fundamental Analysis

NYSE:EHC - New York Stock Exchange, Inc. - US29261A1007 - Common Stock - Currency: USD

120.9  +0.89 (+0.74%)

After market: 120.9 0 (0%)

Fundamental Rating

5

Overall EHC gets a fundamental rating of 5 out of 10. We evaluated EHC against 103 industry peers in the Health Care Providers & Services industry. EHC scores excellent on profitability, but there are concerns on its financial health. While showing a medium growth rate, EHC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year EHC was profitable.
EHC had a positive operating cash flow in the past year.
EHC had positive earnings in each of the past 5 years.
In the past 5 years EHC always reported a positive cash flow from operatings.
EHC Yearly Net Income VS EBIT VS OCF VS FCFEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

EHC has a better Return On Assets (7.41%) than 91.18% of its industry peers.
EHC has a Return On Equity of 22.79%. This is amongst the best in the industry. EHC outperforms 89.22% of its industry peers.
EHC has a Return On Invested Capital of 12.63%. This is amongst the best in the industry. EHC outperforms 88.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EHC is in line with the industry average of 9.60%.
The last Return On Invested Capital (12.63%) for EHC is above the 3 year average (10.83%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.41%
ROE 22.79%
ROIC 12.63%
ROA(3y)5.82%
ROA(5y)5.56%
ROE(3y)21.24%
ROE(5y)20.61%
ROIC(3y)10.83%
ROIC(5y)9.67%
EHC Yearly ROA, ROE, ROICEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

EHC has a Profit Margin of 8.93%. This is amongst the best in the industry. EHC outperforms 93.14% of its industry peers.
EHC's Profit Margin has improved in the last couple of years.
EHC's Operating Margin of 16.76% is amongst the best of the industry. EHC outperforms 94.12% of its industry peers.
In the last couple of years the Operating Margin of EHC has remained more or less at the same level.
EHC's Gross Margin of 95.60% is amongst the best of the industry. EHC outperforms 99.02% of its industry peers.
In the last couple of years the Gross Margin of EHC has remained more or less at the same level.
Industry RankSector Rank
OM 16.76%
PM (TTM) 8.93%
GM 95.6%
OM growth 3Y-0.68%
OM growth 5Y1.36%
PM growth 3Y-6.23%
PM growth 5Y1.66%
GM growth 3Y0.05%
GM growth 5Y-0.17%
EHC Yearly Profit, Operating, Gross MarginsEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EHC is still creating some value.
Compared to 1 year ago, EHC has more shares outstanding
EHC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EHC has an improved debt to assets ratio.
EHC Yearly Shares OutstandingEHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EHC Yearly Total Debt VS Total AssetsEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

EHC has an Altman-Z score of 3.12. This indicates that EHC is financially healthy and has little risk of bankruptcy at the moment.
EHC has a better Altman-Z score (3.12) than 67.65% of its industry peers.
The Debt to FCF ratio of EHC is 6.40, which is on the high side as it means it would take EHC, 6.40 years of fcf income to pay off all of its debts.
EHC's Debt to FCF ratio of 6.40 is in line compared to the rest of the industry. EHC outperforms 57.84% of its industry peers.
EHC has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
EHC's Debt to Equity ratio of 1.08 is on the low side compared to the rest of the industry. EHC is outperformed by 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 6.4
Altman-Z 3.12
ROIC/WACC1.53
WACC8.24%
EHC Yearly LT Debt VS Equity VS FCFEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.06 indicates that EHC should not have too much problems paying its short term obligations.
EHC has a worse Current ratio (1.06) than 71.57% of its industry peers.
EHC has a Quick Ratio of 1.06. This is a normal value and indicates that EHC is financially healthy and should not expect problems in meeting its short term obligations.
EHC's Quick ratio of 1.06 is on the low side compared to the rest of the industry. EHC is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
EHC Yearly Current Assets VS Current LiabilitesEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

EHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.62%, which is quite impressive.
Measured over the past 5 years, EHC shows a small growth in Earnings Per Share. The EPS has been growing by 2.58% on average per year.
The Revenue has grown by 11.21% in the past year. This is quite good.
The Revenue has been growing slightly by 3.13% on average over the past years.
EPS 1Y (TTM)20.62%
EPS 3Y1.63%
EPS 5Y2.58%
EPS Q2Q%22.32%
Revenue 1Y (TTM)11.21%
Revenue growth 3Y10.2%
Revenue growth 5Y3.13%
Sales Q2Q%10.59%

3.2 Future

The Earnings Per Share is expected to grow by 5.48% on average over the next years.
Based on estimates for the next years, EHC will show a quite strong growth in Revenue. The Revenue will grow by 8.05% on average per year.
EPS Next Y14.28%
EPS Next 2Y12.93%
EPS Next 3Y11.77%
EPS Next 5Y5.48%
Revenue Next Year10.12%
Revenue Next 2Y9.34%
Revenue Next 3Y8.73%
Revenue Next 5Y8.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EHC Yearly Revenue VS EstimatesEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
EHC Yearly EPS VS EstimatesEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 25.83 indicates a quite expensive valuation of EHC.
Based on the Price/Earnings ratio, EHC is valued a bit cheaper than 60.78% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.25. EHC is around the same levels.
EHC is valuated rather expensively with a Price/Forward Earnings ratio of 21.40.
The rest of the industry has a similar Price/Forward Earnings ratio as EHC.
EHC is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.83
Fwd PE 21.4
EHC Price Earnings VS Forward Price EarningsEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EHC is valued a bit cheaper than the industry average as 62.75% of the companies are valued more expensively.
EHC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 31.59
EV/EBITDA 11.76
EHC Per share dataEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EHC does not grow enough to justify the current Price/Earnings ratio.
EHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.81
PEG (5Y)10.01
EPS Next 2Y12.93%
EPS Next 3Y11.77%

4

5. Dividend

5.1 Amount

EHC has a yearly dividend return of 0.57%, which is pretty low.
EHC's Dividend Yield is rather good when compared to the industry average which is at 2.45. EHC pays more dividend than 81.37% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, EHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.57%

5.2 History

The dividend of EHC decreases each year by -10.71%.
EHC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-10.71%
Div Incr Years0
Div Non Decr Years0
EHC Yearly Dividends per shareEHC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

EHC pays out 13.19% of its income as dividend. This is a sustainable payout ratio.
DP13.19%
EPS Next 2Y12.93%
EPS Next 3Y11.77%
EHC Yearly Income VS Free CF VS DividendEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
EHC Dividend Payout.EHC Dividend Payout, showing the Payout Ratio.EHC Dividend Payout.PayoutRetained Earnings

ENCOMPASS HEALTH CORP

NYSE:EHC (5/30/2025, 8:04:00 PM)

After market: 120.9 0 (0%)

120.9

+0.89 (+0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners97.31%
Inst Owner Change1.23%
Ins Owners1.14%
Ins Owner Change-2.13%
Market Cap12.21B
Analysts86.25
Price Target132.69 (9.75%)
Short Float %1.9%
Short Ratio2.05
Dividend
Industry RankSector Rank
Dividend Yield 0.57%
Yearly Dividend0.62
Dividend Growth(5Y)-10.71%
DP13.19%
Div Incr Years0
Div Non Decr Years0
Ex-Date07-01 2025-07-01 (0.17)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.53%
Min EPS beat(2)12.94%
Max EPS beat(2)14.11%
EPS beat(4)4
Avg EPS beat(4)10.9%
Min EPS beat(4)8.15%
Max EPS beat(4)14.11%
EPS beat(8)8
Avg EPS beat(8)14.29%
EPS beat(12)11
Avg EPS beat(12)11.51%
EPS beat(16)13
Avg EPS beat(16)9.36%
Revenue beat(2)2
Avg Revenue beat(2)0.75%
Min Revenue beat(2)0.72%
Max Revenue beat(2)0.79%
Revenue beat(4)3
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)0.79%
Revenue beat(8)6
Avg Revenue beat(8)0.56%
Revenue beat(12)9
Avg Revenue beat(12)-1.25%
Revenue beat(16)9
Avg Revenue beat(16)-7.71%
PT rev (1m)11.02%
PT rev (3m)10.95%
EPS NQ rev (1m)2.54%
EPS NQ rev (3m)3.34%
EPS NY rev (1m)4.3%
EPS NY rev (3m)4.54%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)0.49%
Revenue NY rev (1m)0.57%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 25.83
Fwd PE 21.4
P/S 2.21
P/FCF 31.59
P/OCF 11.6
P/B 5.65
P/tB 21.03
EV/EBITDA 11.76
EPS(TTM)4.68
EY3.87%
EPS(NY)5.65
Fwd EY4.67%
FCF(TTM)3.83
FCFY3.17%
OCF(TTM)10.42
OCFY8.62%
SpS54.6
BVpS21.38
TBVpS5.75
PEG (NY)1.81
PEG (5Y)10.01
Profitability
Industry RankSector Rank
ROA 7.41%
ROE 22.79%
ROCE 15.97%
ROIC 12.63%
ROICexc 12.85%
ROICexgc 17.78%
OM 16.76%
PM (TTM) 8.93%
GM 95.6%
FCFM 7.01%
ROA(3y)5.82%
ROA(5y)5.56%
ROE(3y)21.24%
ROE(5y)20.61%
ROIC(3y)10.83%
ROIC(5y)9.67%
ROICexc(3y)10.95%
ROICexc(5y)9.82%
ROICexgc(3y)15.47%
ROICexgc(5y)15.57%
ROCE(3y)13.69%
ROCE(5y)12.22%
ROICexcg growth 3Y1.55%
ROICexcg growth 5Y-5.09%
ROICexc growth 3Y12.32%
ROICexc growth 5Y3.22%
OM growth 3Y-0.68%
OM growth 5Y1.36%
PM growth 3Y-6.23%
PM growth 5Y1.66%
GM growth 3Y0.05%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 6.4
Debt/EBITDA 1.89
Cap/Depr 215.95%
Cap/Sales 12.09%
Interest Coverage 250
Cash Conversion 85.4%
Profit Quality 78.54%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 3.12
F-Score7
WACC8.24%
ROIC/WACC1.53
Cap/Depr(3y)222.37%
Cap/Depr(5y)209.98%
Cap/Sales(3y)12.51%
Cap/Sales(5y)12.54%
Profit Quality(3y)67.08%
Profit Quality(5y)69.21%
High Growth Momentum
Growth
EPS 1Y (TTM)20.62%
EPS 3Y1.63%
EPS 5Y2.58%
EPS Q2Q%22.32%
EPS Next Y14.28%
EPS Next 2Y12.93%
EPS Next 3Y11.77%
EPS Next 5Y5.48%
Revenue 1Y (TTM)11.21%
Revenue growth 3Y10.2%
Revenue growth 5Y3.13%
Sales Q2Q%10.59%
Revenue Next Year10.12%
Revenue Next 2Y9.34%
Revenue Next 3Y8.73%
Revenue Next 5Y8.05%
EBIT growth 1Y21.47%
EBIT growth 3Y9.45%
EBIT growth 5Y4.54%
EBIT Next Year47.5%
EBIT Next 3Y20.4%
EBIT Next 5YN/A
FCF growth 1Y158.81%
FCF growth 3Y29.84%
FCF growth 5Y9.28%
OCF growth 1Y47.26%
OCF growth 3Y11.89%
OCF growth 5Y9.56%